{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T06:55:40Z","timestamp":1765781740710,"version":"3.48.0"},"reference-count":4,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.m2025.0193","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T06:52:58Z","timestamp":1765781578000},"source":"Crossref","is-referenced-by-count":0,"title":["Letters to the Editor"],"prefix":"10.3238","author":[{"given":"Christian A.","family":"Koch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joe M.","family":"Chehade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11437","published-online":{"date-parts":[[2025,12,26]]},"reference":[{"key":"10.3238\/arztebl.m2025.0193_ref1","doi-asserted-by":"crossref","unstructured":"Claassen K, Justenhoven C, Hermann S, et al.: The probability of remaining under active surveillance for localized prostate cancer: An analysis of young patients in the framework of the multicenter ProjuMa registry study. Dtsch Arztebl Int 2025; 122: 401–5.","DOI":"10.3238\/arztebl.m2025.0081"},{"key":"10.3238\/arztebl.m2025.0193_ref2","doi-asserted-by":"crossref","unstructured":"Khera M, Orozco Rendon D, Saffati G, Morgentaler A: Lessons learned from the TRAVERSE trial. J Sex Med 2024; 21: 746–8.","DOI":"10.1093\/jsxmed\/qdae074"},{"key":"10.3238\/arztebl.m2025.0193_ref3","doi-asserted-by":"crossref","unstructured":"Morgentaler A, Conners WP: Testosterone therapy in men with prostate cancer: Literature review, clinical experience, and recommendations. Asian j Androl 2015; 17: 206–11.","DOI":"10.4103\/1008-682X.148067"},{"key":"10.3238\/arztebl.m2025.0193_ref4","doi-asserted-by":"crossref","unstructured":"Kaplan AL, Hu JC, Morgentaler A, Mulhall JP, Schulman CC, Montorsi F: Testosterone therapy in men with prostate cancer. Eur Urol 2016; 69: 894–903.","DOI":"10.1016\/j.eururo.2015.12.005"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2025.0193","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T06:53:47Z","timestamp":1765781627000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2025.0193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":4,"URL":"https:\/\/doi.org\/10.3238\/arztebl.m2025.0193","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,26]]}}}